Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Douxfils

Showing results (81-90 of 221) with videos related to

Pageof 23
Sort By:
Case Reports in Infectious Diseases|September 9, 2024
Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated PopulationConstant Gillot, Jean-Louis Bayart, Vincent Maloteau, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2022
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and DrospirenoneLaure Morimont, Maud Jost, Ulysse Gaspard, et al.
Heliyon|January 15, 2025
Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series studyMarie Didembourg, Clara David, Laure Morimont, et al.
Clinical Chemistry|June 3, 2020
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total AntibodiesJulien Favresse, Christine Eucher, Marc Elsen, et al.
Frontiers in Public Health|April 16, 2026
Commentary: 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South KoreaMédéa Locquet, Charlotte Beaudart, Jonathan Douxfils, et al.
Research and Practice in Thrombosis and Haemostasis|September 18, 2024
Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by 2 different plasma-based fibrinolysis assaysMarie-Astrid van Dievoet, Karim Zouaoui Boudjeltia, Madeleine Rousseaux, et al.
International Journal of Laboratory Hematology|December 14, 2020
Assessment of acquired activated protein C resistance with the FibWave and comparison with the ETP-based APC resistanceJonathan Evrard, Laure Morimont, Marie Didembourg, et al.
Thrombosis Research|June 18, 2018
The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugsL Joost van Pelt, Michaël V Lukens, Sophie Testa, et al.
Vaccines|December 23, 2022
Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia SyndromeConstant Gillot, Julien Favresse, Vincent Maloteau, et al.
Thrombosis and Haemostasis|July 13, 2013
Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxabanJonathan Douxfils, Anne Tamigniau, Bernard Chatelain, et al.
Pageof 23

Showing results (81-90 of 221) with videos related to

Sort By:
Pageof 23
Case Reports in Infectious Diseases|September 9, 2024
Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated PopulationConstant Gillot, Jean-Louis Bayart, Vincent Maloteau, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2022
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and DrospirenoneLaure Morimont, Maud Jost, Ulysse Gaspard, et al.
Heliyon|January 15, 2025
Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series studyMarie Didembourg, Clara David, Laure Morimont, et al.
Clinical Chemistry|June 3, 2020
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total AntibodiesJulien Favresse, Christine Eucher, Marc Elsen, et al.
Frontiers in Public Health|April 16, 2026
Commentary: 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South KoreaMédéa Locquet, Charlotte Beaudart, Jonathan Douxfils, et al.
Research and Practice in Thrombosis and Haemostasis|September 18, 2024
Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by 2 different plasma-based fibrinolysis assaysMarie-Astrid van Dievoet, Karim Zouaoui Boudjeltia, Madeleine Rousseaux, et al.
International Journal of Laboratory Hematology|December 14, 2020
Assessment of acquired activated protein C resistance with the FibWave and comparison with the ETP-based APC resistanceJonathan Evrard, Laure Morimont, Marie Didembourg, et al.
Thrombosis Research|June 18, 2018
The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugsL Joost van Pelt, Michaël V Lukens, Sophie Testa, et al.
Vaccines|December 23, 2022
Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia SyndromeConstant Gillot, Julien Favresse, Vincent Maloteau, et al.
Thrombosis and Haemostasis|July 13, 2013
Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxabanJonathan Douxfils, Anne Tamigniau, Bernard Chatelain, et al.
Pageof 23